A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...
On February 2, 2024, six senators known as the “Gang of Six” – John Thune, Debbie Stabenow, Shelley Moore Capito, Tammy Baldwin, Jerry Moran and Ben Cardin – released a discussion draft bill intended ...
The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...
Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...
The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.
Critics of the controversial 340B program applauded a new bill that they say restores the decades-old law's patient-focused goals. Hospitals, who have increasingly leaned on the drug discounts in ...
Though it used the majority of its public comment letter making the case against drug manufacturer-preferred rebates for 340B drugs, the American Hospital Association also outlined "bare minimum ...
One of the critical components for Mainers as they navigate the medical quagmire of insurance, providers and treatment is obtaining effective and safe drugs. Cancer treatment is often a long, taxing ...
PHILADELPHIA, PA, UNITED STATES, February 4, 2026 /EINPresswire.com/ — RxParadigm, an end-to-end 340B drug administration platform with integrated capabilities to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results